https://assets.capyfin.com/instruments/678fdc13234e27009c5d591b.png avatar
Leidos
🇺🇸 NYSE:LDOS
•
Jan 03

Leidos Q4 2024 Earnings Report

Key Takeaways

Leidos reported strong Q4 FY24 results, with revenue increasing 10% year-over-year to $4.37 billion and net income rising 23% to $282 million. Adjusted EPS reached $2.37, a 19% increase from Q4 FY23, driven by growth in managed health services and improved program execution. Operating income stood at $421 million, and free cash flow was $213 million.

Total Revenue
$4.37B
Previous year: $3.98B
+9.7%
EPS
$2.37
Previous year: $1.99
+19.1%
Net Income Margin
6.5%
Previous year: 5.8%
+12.1%
Operating Income Margin
9.6%
Previous year: 9.1%
+5.5%
Adjusted EBITDA
$508M
Previous year: $452M
+12.4%
Gross Profit
$693M
Previous year: $595M
+16.5%
Cash and Equivalents
$943M
Previous year: $777M
+21.4%
Free Cash Flow
$213M
Previous year: $226M
-5.8%
Total Assets
$13.1B
Previous year: $12.7B
+3.2%

Leidos Revenue

Leidos EPS

Leidos Revenue by Segment

Forward Guidance

Leidos expects continued revenue and earnings growth in FY25, driven by strong demand in key segments and operational efficiencies.

Positive Outlook

  • Revenue projected between $16.9B - $17.3B.
  • Non-GAAP diluted EPS expected between $10.35 - $10.75.
  • Adjusted EBITDA margin forecasted in mid-to-high 12%.
  • Strong backlog of $43.6B supports future revenue visibility.
  • Expected cash flows from operations around $1.45B.

Challenges Ahead

  • Potential headwinds from macroeconomic uncertainties.
  • Continued cost pressures in fixed-price programs.
  • Challenges in the security products business mix.
  • Expected impact from contract rebaselining in UK operations.
  • Increased investments in growth affecting near-term margins.

Revenue & Expenses

Visualization of income flow from segment revenue to net income